AbbVie Inc (ABBV)
Quick ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cash | US$ in thousands | 5,524,000 | 12,814,000 | 9,201,000 | 9,746,000 | 8,449,000 |
Short-term investments | US$ in thousands | 31,000 | 2,000 | 28,000 | 84,000 | 30,000 |
Receivables | US$ in thousands | — | — | — | — | — |
Total current liabilities | US$ in thousands | 38,749,000 | 37,841,000 | 29,538,000 | 35,194,000 | 28,661,000 |
Quick ratio | 0.14 | 0.34 | 0.31 | 0.28 | 0.30 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($5,524,000K
+ $31,000K
+ $—K)
÷ $38,749,000K
= 0.14
The quick ratio of AbbVie Inc has shown some fluctuation over the years with values of 0.30 in 2020, 0.28 in 2021, 0.31 in 2022, 0.34 in 2023, and a significant decrease to 0.14 in 2024. The quick ratio compares the company's most liquid assets to its current liabilities, providing insight into its ability to cover its short-term obligations with its highly liquid assets. A quick ratio below 1 indicates that the company may have difficulty meeting its short-term obligations. In this case, the trend of decreasing quick ratio values from 2020 to 2024 may raise concerns about AbbVie's liquidity position and its ability to cover its current liabilities. Further analysis of the company's financial health and operational efficiency may be necessary to understand the underlying reasons for the fluctuation in the quick ratio.
Peer comparison
Dec 31, 2024